Christopher William Schultz, PhD

Christopher William Schultz, resized

Educational Background

PostDoc, National Cancer Institute, 2025

PhD, Genetics, Genomics and Biology of Cancer, Thomas Jefferson University, 2020

BS, Chemistry, Drexel University 2015

Memberships

AACR Membership

Honors & Awards

K99/R00 2023-Present

FARE travel award NIH – competitive travel award 2022

NCI Graduate Student Recruitment Program – Competitive program recruiting graduate students to become fellows at the NCI 2019

Lab Overview

The Schultz lab aims to further understand small cell lung cancer and unique vulnerabilities associated with neuroendocrine differentiation and characteristic mutations present in small cell lung cancer. All work at the Schultz lab is designed to be translationally relevant, with every project aimed at near-term translatability to the clinic if successful.

Selected Publications

https://orcid.org/0000-0001-5731-2847

Additional Publications

1)Schultz CW et al ATR inhibition augments the efficacy of lurbinectedin in small cell lung cancer, PMID:37491889, 2023, EMBO Molecular Medicine 

2)Lorinc S Pongor, Schultz CW et al… Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes, PMID: 36715552, 2023, Cancer Discovery 

3) Schultz CW et al The FDA approved anthelmintic Pyrvinium Pamoate inhibits pancreatic adenocarcinoma through inhibiting HuR and mitochondrial survival pathways, PMID: 34413127, 2021, Molecular Cancer Therapeutics

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...